Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Cluster Randomised Trial comparing outcomes of early psychosis care by a specialist team and augmented community mental health teams (CMHTs)
ISRCTN ISRCTN58681229
ClinicalTrials.gov identifier
Public title Cluster Randomised Trial comparing outcomes of early psychosis care by a specialist team and augmented community mental health teams (CMHTs)
Scientific title
Acronym SATS
Serial number at source 03/38
Study hypothesis That the provision of services by specialist teams for people experiencing a first psychotic episode confers no advantage over the provision of services for first episode psychosis provided by augmented non-specialist teams
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain First Episode Psychosis
Participants - inclusion criteria All patients with a first psychotic episode aged between 18 and 34 referred to augmented and specialist services who are resident in the catchment area of the services
Participants - exclusion criteria People will not be accepted for assessment if
1. Their symptoms appear secondary to a primary diagnosis of emotionally unstable personality disorder or post-traumatic stress disorder
2. Their symptoms appear to be the clear result of drug induced psychosis, narrowly defined. Psychosis will only be viewed as drug induced if symptoms have emerged suddenly in the context of intoxication without any previous decline in functioning and if they subside within a few days
3. They have elevated mood but no psychotic symptoms
4. Their psychotic symptoms are not associated with any decline in functioning, disruption of development, distress or risk
5. They are thought to have taken antipsychotic medication for at least 6 weeks
6. They were first diagnosed as having a psychotic illness by a specialist mental health service more than 1 year ago
Anticipated start date 31/01/2005
Anticipated end date 31/01/2008
Status of trial Completed
Patient information material
Target number of participants 250
Interventions 1. Specialist Early Intervention Service - a dedicated team specialising solely in the care of first episode psychosis. The team is multiprofessional and community based, has appropriate inpatient services and would be expected to maintain contact with all first episode patients for a period of 3 years.
2. Augmented community mental health teams. These community based multiprofessional teams provide general mental health services to defined geographical catchment areas. For the purpose of the trial the service will be augmented by two whole time equivalent staff who will focus solely on the care of first episode psychosis and will be expected to maintain contact with patients for a three year period.
Primary outcome measure(s) Proportion relapsing within 2 years of entry into the trial
Secondary outcome measure(s) 1. Time to relapse
2. Whether engaged in paid employment or education for at leeast 15 hours per week
3. Quality of Life (MECCA)
Sources of funding The British Psychological Society (UK) - Programme Grant
Trial website
Publications
Contact name Dr  Sonia  Johnson
  Address Department of Mental Health Sciences
Riding House Street
  City/town London
  Zip/Postcode W1W 7EY
  Country United Kingdom
  Email s.johnson@ucl.ac.uk
Sponsor Camden and Islington Mental Health and Social Care Trust (UK)
  Address St Pancras Hospital
4 St Pancras Way
  City/town London
  Zip/Postcode NW1 0PE
  Country United Kingdom
  Tel +44 (0)20 7530 3000
  Email candi@nhs.uk
  Sponsor website: http://www.candi.nhs.uk
Date applied 02/08/2005
Last edited 15/07/2010
Date ISRCTN assigned 11/11/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central